Clinical Trial Update: A Study of NOX66 Plus Doxorubicin in Anthracycline-naïve, Adult Patients With Soft Tissue Sarcoma [Phase 1]

View source ↗

Summary

A Phase 1 study of NOX66 in combination with doxorubicin for anthracycline-naïve adults with metastatic soft-tissue sarcoma was terminated, with trial results p…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Soft-tissue Sarcoma

Drugs mentioned

• NOX66

Snippet

Sponsor: Noxopharm Limited | Conditions: Metastatic Soft-tissue Sarcoma | Phase 1 | Status: TERMINATED | Results posted: 2025-01-06